Biogen Pharmachem Ltd. Files SEBI Compliance Certificate for March Quarter

SEBIEXCHANGE
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Biogen Pharmachem Ltd. Files SEBI Compliance Certificate for March Quarter
Overview

Biogen Pharmachem Industries Ltd. submitted a compliance certificate to the BSE for the quarter ending March 31, 2026. The filing, made under SEBI regulations, includes confirmation from registrar Satellite Corporate Services Pvt. Ltd. that no physical share certificates were received for dematerialization during the period.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Biogen Pharmachem Industries Ltd. has submitted its compliance certificate to the BSE for the quarter ending March 31, 2026. The filing adheres to SEBI regulations, specifically concerning depositories and participants.

Registrar Satellite Corporate Services Pvt. Ltd. confirmed in the certificate that no physical share certificates were processed for dematerialization during this period. This is a standard procedural confirmation that reassures stakeholders about the company's adherence to modern trading practices and regulatory oversight.

Established in 1995 and headquartered in Rajkot, India, Biogen Pharmachem Industries Ltd. operates in the trading of shares and securities. The company has a history of submitting these quarterly compliance reports, consistently affirming the non-receipt of physical certificates for dematerialization.

These regular filings underscore Biogen Pharmachem's commitment to regulatory compliance and reflect the broader industry trend towards fully electronic shareholding. For investors, timely submission of such reports serves as a key indicator of corporate governance.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.